{"id":1335,"date":"2019-09-14T13:12:00","date_gmt":"2019-09-14T13:12:00","guid":{"rendered":"https:\/\/blogs.bmj.com\/jmg\/?p=1335"},"modified":"2026-02-24T00:28:35","modified_gmt":"2026-02-24T00:28:35","slug":"germline-brca1-and-brca2-testing-for-breast-cancer-survivors","status":"publish","type":"post","link":"https:\/\/blogs.bmj.com\/jmg\/2019\/09\/14\/germline-brca1-and-brca2-testing-for-breast-cancer-survivors\/","title":{"rendered":"Germline BRCA1 and BRCA2 testing for breast cancer survivors (Contributed by Dr Zoe Kemp)"},"content":{"rendered":"

For patients with early breast cancer knowledge of germline BRCA1\/2<\/em> status increasingly influences management as well as informing future cancer risk for patients and their families. Newly diagnosed patients are now benefiting from expanded access to testing. To extend this provision to breast cancer survivors, we embedded a Senior Genetic Counsellor in the Breast Unit Open Access Follow Up programme to identify patients suitable for genetics review 5 years after their breast cancer diagnosis. This collaboration resulted in the identification of further carriers and strengthened the multidisciplinary working of the two teams. (https:\/\/jmg.bmj.com\/content\/early\/2019\/09\/10\/jmedgenet-2019-106420<\/a> )<\/p>\n","protected":false},"excerpt":{"rendered":"

For patients with early breast cancer knowledge of germline BRCA1\/2 status increasingly influences management as well as informing future cancer risk for patients and their families. Newly diagnosed patients are now benefiting from expanded access to testing. To extend this provision to breast cancer survivors, we embedded a Senior Genetic Counsellor in the Breast Unit […]<\/p>\n

Read More…<\/a><\/p>\n","protected":false},"author":123,"featured_media":0,"comment_status":"open","ping_status":"closed","sticky":false,"template":"","format":"standard","meta":{"footnotes":""},"categories":[1],"tags":[],"class_list":["post-1335","post","type-post","status-publish","format-standard","hentry","category-uncategorized"],"yoast_head":"\nGermline BRCA1 and BRCA2 testing for breast cancer survivors (Contributed by Dr Zoe Kemp) - JMG Contact blog<\/title>\n<meta name=\"robots\" content=\"index, follow, max-snippet:-1, max-image-preview:large, max-video-preview:-1\" \/>\n<link rel=\"canonical\" href=\"https:\/\/blogs.bmj.com\/jmg\/2019\/09\/14\/germline-brca1-and-brca2-testing-for-breast-cancer-survivors\/\" \/>\n<meta property=\"og:locale\" content=\"en_US\" \/>\n<meta property=\"og:type\" content=\"article\" \/>\n<meta property=\"og:title\" content=\"Germline BRCA1 and BRCA2 testing for breast cancer survivors (Contributed by Dr Zoe Kemp) - JMG Contact blog\" \/>\n<meta property=\"og:description\" content=\"For patients with early breast cancer knowledge of germline BRCA1\/2 status increasingly influences management as well as informing future cancer risk for patients and their families. Newly diagnosed patients are now benefiting from expanded access to testing. To extend this provision to breast cancer survivors, we embedded a Senior Genetic Counsellor in the Breast Unit [...]Read More...\" \/>\n<meta property=\"og:url\" content=\"https:\/\/blogs.bmj.com\/jmg\/2019\/09\/14\/germline-brca1-and-brca2-testing-for-breast-cancer-survivors\/\" \/>\n<meta property=\"og:site_name\" content=\"JMG Contact blog\" \/>\n<meta property=\"article:published_time\" content=\"2019-09-14T13:12:00+00:00\" \/>\n<meta property=\"article:modified_time\" content=\"2026-02-24T00:28:35+00:00\" \/>\n<meta name=\"author\" content=\"hqqu\" \/>\n<meta name=\"twitter:card\" content=\"summary_large_image\" \/>\n<meta name=\"twitter:creator\" content=\"@HuiQiQu\" \/>\n<meta name=\"twitter:label1\" content=\"Written by\" \/>\n\t<meta name=\"twitter:data1\" content=\"hqqu\" \/>\n\t<meta name=\"twitter:label2\" content=\"Est. reading time\" \/>\n\t<meta name=\"twitter:data2\" content=\"1 minute\" \/>\n<script type=\"application\/ld+json\" class=\"yoast-schema-graph\">{\"@context\":\"https:\\\/\\\/schema.org\",\"@graph\":[{\"@type\":\"Article\",\"@id\":\"https:\\\/\\\/blogs.bmj.com\\\/jmg\\\/2019\\\/09\\\/14\\\/germline-brca1-and-brca2-testing-for-breast-cancer-survivors\\\/#article\",\"isPartOf\":{\"@id\":\"https:\\\/\\\/blogs.bmj.com\\\/jmg\\\/2019\\\/09\\\/14\\\/germline-brca1-and-brca2-testing-for-breast-cancer-survivors\\\/\"},\"author\":{\"name\":\"hqqu\",\"@id\":\"https:\\\/\\\/blogs.bmj.com\\\/jmg\\\/#\\\/schema\\\/person\\\/be0250f8d5b52412c3e7c222dabd591b\"},\"headline\":\"Germline BRCA1 and BRCA2 testing for breast cancer survivors (Contributed by Dr Zoe Kemp)\",\"datePublished\":\"2019-09-14T13:12:00+00:00\",\"dateModified\":\"2026-02-24T00:28:35+00:00\",\"mainEntityOfPage\":{\"@id\":\"https:\\\/\\\/blogs.bmj.com\\\/jmg\\\/2019\\\/09\\\/14\\\/germline-brca1-and-brca2-testing-for-breast-cancer-survivors\\\/\"},\"wordCount\":113,\"commentCount\":0,\"publisher\":{\"@id\":\"https:\\\/\\\/blogs.bmj.com\\\/jmg\\\/#organization\"},\"inLanguage\":\"en-US\",\"potentialAction\":[{\"@type\":\"CommentAction\",\"name\":\"Comment\",\"target\":[\"https:\\\/\\\/blogs.bmj.com\\\/jmg\\\/2019\\\/09\\\/14\\\/germline-brca1-and-brca2-testing-for-breast-cancer-survivors\\\/#respond\"]}]},{\"@type\":\"WebPage\",\"@id\":\"https:\\\/\\\/blogs.bmj.com\\\/jmg\\\/2019\\\/09\\\/14\\\/germline-brca1-and-brca2-testing-for-breast-cancer-survivors\\\/\",\"url\":\"https:\\\/\\\/blogs.bmj.com\\\/jmg\\\/2019\\\/09\\\/14\\\/germline-brca1-and-brca2-testing-for-breast-cancer-survivors\\\/\",\"name\":\"Germline BRCA1 and BRCA2 testing for breast cancer survivors (Contributed by Dr Zoe Kemp) - JMG Contact blog\",\"isPartOf\":{\"@id\":\"https:\\\/\\\/blogs.bmj.com\\\/jmg\\\/#website\"},\"datePublished\":\"2019-09-14T13:12:00+00:00\",\"dateModified\":\"2026-02-24T00:28:35+00:00\",\"breadcrumb\":{\"@id\":\"https:\\\/\\\/blogs.bmj.com\\\/jmg\\\/2019\\\/09\\\/14\\\/germline-brca1-and-brca2-testing-for-breast-cancer-survivors\\\/#breadcrumb\"},\"inLanguage\":\"en-US\",\"potentialAction\":[{\"@type\":\"ReadAction\",\"target\":[\"https:\\\/\\\/blogs.bmj.com\\\/jmg\\\/2019\\\/09\\\/14\\\/germline-brca1-and-brca2-testing-for-breast-cancer-survivors\\\/\"]}]},{\"@type\":\"BreadcrumbList\",\"@id\":\"https:\\\/\\\/blogs.bmj.com\\\/jmg\\\/2019\\\/09\\\/14\\\/germline-brca1-and-brca2-testing-for-breast-cancer-survivors\\\/#breadcrumb\",\"itemListElement\":[{\"@type\":\"ListItem\",\"position\":1,\"name\":\"Home\",\"item\":\"https:\\\/\\\/blogs.bmj.com\\\/jmg\\\/\"},{\"@type\":\"ListItem\",\"position\":2,\"name\":\"Germline BRCA1 and BRCA2 testing for breast cancer survivors (Contributed by Dr Zoe Kemp)\"}]},{\"@type\":\"WebSite\",\"@id\":\"https:\\\/\\\/blogs.bmj.com\\\/jmg\\\/#website\",\"url\":\"https:\\\/\\\/blogs.bmj.com\\\/jmg\\\/\",\"name\":\"JMG Contact blog\",\"description\":\"JMG Contact blog\",\"publisher\":{\"@id\":\"https:\\\/\\\/blogs.bmj.com\\\/jmg\\\/#organization\"},\"potentialAction\":[{\"@type\":\"SearchAction\",\"target\":{\"@type\":\"EntryPoint\",\"urlTemplate\":\"https:\\\/\\\/blogs.bmj.com\\\/jmg\\\/?s={search_term_string}\"},\"query-input\":{\"@type\":\"PropertyValueSpecification\",\"valueRequired\":true,\"valueName\":\"search_term_string\"}}],\"inLanguage\":\"en-US\"},{\"@type\":\"Organization\",\"@id\":\"https:\\\/\\\/blogs.bmj.com\\\/jmg\\\/#organization\",\"name\":\"JMG Contact blog\",\"url\":\"https:\\\/\\\/blogs.bmj.com\\\/jmg\\\/\",\"logo\":{\"@type\":\"ImageObject\",\"inLanguage\":\"en-US\",\"@id\":\"https:\\\/\\\/blogs.bmj.com\\\/jmg\\\/#\\\/schema\\\/logo\\\/image\\\/\",\"url\":\"https:\\\/\\\/blogs.bmj.com\\\/jmg\\\/files\\\/2017\\\/10\\\/blog-logo-jmg.png\",\"contentUrl\":\"https:\\\/\\\/blogs.bmj.com\\\/jmg\\\/files\\\/2017\\\/10\\\/blog-logo-jmg.png\",\"width\":300,\"height\":34,\"caption\":\"JMG Contact blog\"},\"image\":{\"@id\":\"https:\\\/\\\/blogs.bmj.com\\\/jmg\\\/#\\\/schema\\\/logo\\\/image\\\/\"}},{\"@type\":\"Person\",\"@id\":\"https:\\\/\\\/blogs.bmj.com\\\/jmg\\\/#\\\/schema\\\/person\\\/be0250f8d5b52412c3e7c222dabd591b\",\"name\":\"hqqu\",\"image\":{\"@type\":\"ImageObject\",\"inLanguage\":\"en-US\",\"@id\":\"https:\\\/\\\/secure.gravatar.com\\\/avatar\\\/920bc4e81500cde88def4bfd7775029cb154e422c5460b9cf80d5c47137d6f35?s=96&d=mm&r=g\",\"url\":\"https:\\\/\\\/secure.gravatar.com\\\/avatar\\\/920bc4e81500cde88def4bfd7775029cb154e422c5460b9cf80d5c47137d6f35?s=96&d=mm&r=g\",\"contentUrl\":\"https:\\\/\\\/secure.gravatar.com\\\/avatar\\\/920bc4e81500cde88def4bfd7775029cb154e422c5460b9cf80d5c47137d6f35?s=96&d=mm&r=g\",\"caption\":\"hqqu\"},\"description\":\"Huiqi Qu has a background as a physician trained in internal medicine and a PhD in Experimental Medicine (Endocrinology). His research applies human genetics and multi-omics to complex and pediatric diseases, including GWAS, polygenic risk scores (PRS), single-cell transcriptomics, and integrative genomics to support precision medicine and clinical translation.\",\"sameAs\":[\"https:\\\/\\\/x.com\\\/HuiQiQu\"],\"url\":\"https:\\\/\\\/blogs.bmj.com\\\/jmg\\\/author\\\/hqiqu\\\/\"}]}<\/script>\n<!-- \/ Yoast SEO plugin. -->","yoast_head_json":{"title":"Germline BRCA1 and BRCA2 testing for breast cancer survivors (Contributed by Dr Zoe Kemp) - JMG Contact blog","robots":{"index":"index","follow":"follow","max-snippet":"max-snippet:-1","max-image-preview":"max-image-preview:large","max-video-preview":"max-video-preview:-1"},"canonical":"https:\/\/blogs.bmj.com\/jmg\/2019\/09\/14\/germline-brca1-and-brca2-testing-for-breast-cancer-survivors\/","og_locale":"en_US","og_type":"article","og_title":"Germline BRCA1 and BRCA2 testing for breast cancer survivors (Contributed by Dr Zoe Kemp) - JMG Contact blog","og_description":"For patients with early breast cancer knowledge of germline BRCA1\/2 status increasingly influences management as well as informing future cancer risk for patients and their families. Newly diagnosed patients are now benefiting from expanded access to testing. To extend this provision to breast cancer survivors, we embedded a Senior Genetic Counsellor in the Breast Unit [...]Read More...","og_url":"https:\/\/blogs.bmj.com\/jmg\/2019\/09\/14\/germline-brca1-and-brca2-testing-for-breast-cancer-survivors\/","og_site_name":"JMG Contact blog","article_published_time":"2019-09-14T13:12:00+00:00","article_modified_time":"2026-02-24T00:28:35+00:00","author":"hqqu","twitter_card":"summary_large_image","twitter_creator":"@HuiQiQu","twitter_misc":{"Written by":"hqqu","Est. reading time":"1 minute"},"schema":{"@context":"https:\/\/schema.org","@graph":[{"@type":"Article","@id":"https:\/\/blogs.bmj.com\/jmg\/2019\/09\/14\/germline-brca1-and-brca2-testing-for-breast-cancer-survivors\/#article","isPartOf":{"@id":"https:\/\/blogs.bmj.com\/jmg\/2019\/09\/14\/germline-brca1-and-brca2-testing-for-breast-cancer-survivors\/"},"author":{"name":"hqqu","@id":"https:\/\/blogs.bmj.com\/jmg\/#\/schema\/person\/be0250f8d5b52412c3e7c222dabd591b"},"headline":"Germline BRCA1 and BRCA2 testing for breast cancer survivors (Contributed by Dr Zoe Kemp)","datePublished":"2019-09-14T13:12:00+00:00","dateModified":"2026-02-24T00:28:35+00:00","mainEntityOfPage":{"@id":"https:\/\/blogs.bmj.com\/jmg\/2019\/09\/14\/germline-brca1-and-brca2-testing-for-breast-cancer-survivors\/"},"wordCount":113,"commentCount":0,"publisher":{"@id":"https:\/\/blogs.bmj.com\/jmg\/#organization"},"inLanguage":"en-US","potentialAction":[{"@type":"CommentAction","name":"Comment","target":["https:\/\/blogs.bmj.com\/jmg\/2019\/09\/14\/germline-brca1-and-brca2-testing-for-breast-cancer-survivors\/#respond"]}]},{"@type":"WebPage","@id":"https:\/\/blogs.bmj.com\/jmg\/2019\/09\/14\/germline-brca1-and-brca2-testing-for-breast-cancer-survivors\/","url":"https:\/\/blogs.bmj.com\/jmg\/2019\/09\/14\/germline-brca1-and-brca2-testing-for-breast-cancer-survivors\/","name":"Germline BRCA1 and BRCA2 testing for breast cancer survivors (Contributed by Dr Zoe Kemp) - JMG Contact blog","isPartOf":{"@id":"https:\/\/blogs.bmj.com\/jmg\/#website"},"datePublished":"2019-09-14T13:12:00+00:00","dateModified":"2026-02-24T00:28:35+00:00","breadcrumb":{"@id":"https:\/\/blogs.bmj.com\/jmg\/2019\/09\/14\/germline-brca1-and-brca2-testing-for-breast-cancer-survivors\/#breadcrumb"},"inLanguage":"en-US","potentialAction":[{"@type":"ReadAction","target":["https:\/\/blogs.bmj.com\/jmg\/2019\/09\/14\/germline-brca1-and-brca2-testing-for-breast-cancer-survivors\/"]}]},{"@type":"BreadcrumbList","@id":"https:\/\/blogs.bmj.com\/jmg\/2019\/09\/14\/germline-brca1-and-brca2-testing-for-breast-cancer-survivors\/#breadcrumb","itemListElement":[{"@type":"ListItem","position":1,"name":"Home","item":"https:\/\/blogs.bmj.com\/jmg\/"},{"@type":"ListItem","position":2,"name":"Germline BRCA1 and BRCA2 testing for breast cancer survivors (Contributed by Dr Zoe Kemp)"}]},{"@type":"WebSite","@id":"https:\/\/blogs.bmj.com\/jmg\/#website","url":"https:\/\/blogs.bmj.com\/jmg\/","name":"JMG Contact blog","description":"JMG Contact blog","publisher":{"@id":"https:\/\/blogs.bmj.com\/jmg\/#organization"},"potentialAction":[{"@type":"SearchAction","target":{"@type":"EntryPoint","urlTemplate":"https:\/\/blogs.bmj.com\/jmg\/?s={search_term_string}"},"query-input":{"@type":"PropertyValueSpecification","valueRequired":true,"valueName":"search_term_string"}}],"inLanguage":"en-US"},{"@type":"Organization","@id":"https:\/\/blogs.bmj.com\/jmg\/#organization","name":"JMG Contact blog","url":"https:\/\/blogs.bmj.com\/jmg\/","logo":{"@type":"ImageObject","inLanguage":"en-US","@id":"https:\/\/blogs.bmj.com\/jmg\/#\/schema\/logo\/image\/","url":"https:\/\/blogs.bmj.com\/jmg\/files\/2017\/10\/blog-logo-jmg.png","contentUrl":"https:\/\/blogs.bmj.com\/jmg\/files\/2017\/10\/blog-logo-jmg.png","width":300,"height":34,"caption":"JMG Contact blog"},"image":{"@id":"https:\/\/blogs.bmj.com\/jmg\/#\/schema\/logo\/image\/"}},{"@type":"Person","@id":"https:\/\/blogs.bmj.com\/jmg\/#\/schema\/person\/be0250f8d5b52412c3e7c222dabd591b","name":"hqqu","image":{"@type":"ImageObject","inLanguage":"en-US","@id":"https:\/\/secure.gravatar.com\/avatar\/920bc4e81500cde88def4bfd7775029cb154e422c5460b9cf80d5c47137d6f35?s=96&d=mm&r=g","url":"https:\/\/secure.gravatar.com\/avatar\/920bc4e81500cde88def4bfd7775029cb154e422c5460b9cf80d5c47137d6f35?s=96&d=mm&r=g","contentUrl":"https:\/\/secure.gravatar.com\/avatar\/920bc4e81500cde88def4bfd7775029cb154e422c5460b9cf80d5c47137d6f35?s=96&d=mm&r=g","caption":"hqqu"},"description":"Huiqi Qu has a background as a physician trained in internal medicine and a PhD in Experimental Medicine (Endocrinology). His research applies human genetics and multi-omics to complex and pediatric diseases, including GWAS, polygenic risk scores (PRS), single-cell transcriptomics, and integrative genomics to support precision medicine and clinical translation.","sameAs":["https:\/\/x.com\/HuiQiQu"],"url":"https:\/\/blogs.bmj.com\/jmg\/author\/hqiqu\/"}]}},"_links":{"self":[{"href":"https:\/\/blogs.bmj.com\/jmg\/wp-json\/wp\/v2\/posts\/1335","targetHints":{"allow":["GET"]}}],"collection":[{"href":"https:\/\/blogs.bmj.com\/jmg\/wp-json\/wp\/v2\/posts"}],"about":[{"href":"https:\/\/blogs.bmj.com\/jmg\/wp-json\/wp\/v2\/types\/post"}],"author":[{"embeddable":true,"href":"https:\/\/blogs.bmj.com\/jmg\/wp-json\/wp\/v2\/users\/123"}],"replies":[{"embeddable":true,"href":"https:\/\/blogs.bmj.com\/jmg\/wp-json\/wp\/v2\/comments?post=1335"}],"version-history":[{"count":0,"href":"https:\/\/blogs.bmj.com\/jmg\/wp-json\/wp\/v2\/posts\/1335\/revisions"}],"wp:attachment":[{"href":"https:\/\/blogs.bmj.com\/jmg\/wp-json\/wp\/v2\/media?parent=1335"}],"wp:term":[{"taxonomy":"category","embeddable":true,"href":"https:\/\/blogs.bmj.com\/jmg\/wp-json\/wp\/v2\/categories?post=1335"},{"taxonomy":"post_tag","embeddable":true,"href":"https:\/\/blogs.bmj.com\/jmg\/wp-json\/wp\/v2\/tags?post=1335"}],"curies":[{"name":"wp","href":"https:\/\/api.w.org\/{rel}","templated":true}]}}